Prelude Therapeutics Cash Flow Statement (2019-2026) | PRLD

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-170.14M-108.38M-41.59M-37.16M-42.51M-144.44M-38.22M-37.80M-35.98M-37.86M-77.64M-79.85M-76.48M-34.36M-57.55M-54.47M-42.02M-18.08M-34.44M-52.71M
Share-based Compensation (Quarter)
7.03M20.36M6.83M6.03M6.44M5.84M6.26M6.73M6.71M5.91M5.55M6.10M5.93M3.77M0.01M3.81M2.42M1.84M0.05M2.03M
Cash from Operations (Quarter)
-21.77M-25.70M-21.89M-18.47M-20.44M-22.93M-30.13M-27.67M-25.68M-23.58M-31.79M-23.06M-27.30M-20.74M-34.23M-26.07M-19.11M23.12M-21.68M-15.57M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-1.01M-0.75M-1.04M-0.99M0.18M0.45M0.36M1.60M1.07M1.54M1.33M0.81M0.95M-0.08M0.21M0.05M0.19M0.39M0.31M
Amortization of Deferred Charges (Quarter)
0.36M0.40M0.41M0.43M0.44M0.44M0.43M0.44M0.45M0.61M0.41M0.40M0.39M0.39M0.38M0.38M0.38M0.38M0.39M0.39M
Depreciation & Amortization (CF) (Quarter)
0.27M0.29M0.31M0.32M0.34M0.36M0.28M0.28M0.28M0.33M0.43M0.45M0.41M0.49M0.43M0.43M0.42M0.42M0.39M0.35M
Change in Working Capital
Change in Account Payables (Quarter)
4.51M-3.93M0.00M-0.84M3.73M-3.24M0.37M-1.71M-0.47M-0.47M0.63M1.08M-0.21M1.81M-1.91M-0.85M-2.43M1.27M-1.88M-0.15M
Change in Accured Expenses (Quarter)
0.46M2.86M-0.40M0.90M3.17M3.17M-1.90M-2.59M2.62M4.39M-5.69M1.23M2.09M1.57M-3.97M1.87M-0.37M-0.52M-6.60M1.92M
Other Working Capital Changes (Quarter)
2.00M0.43M0.42M0.43M0.43M0.43M0.35M0.54M1.16M-1.76M-0.64M0.86M-0.11M-0.48M-0.05M0.05M1.09M-1.06M-4.58M-5.70M
Investing Activities
Capital Expenditures (Quarter)
1.64M-1.22M0.35M1.36M-1.39M-0.23M0.81M0.98M0.59M1.13M0.29M0.36M0.06M-0.70M0.05M0.02M0.03M
Change in Acquisitions & Divestments (Quarter)
42.50M45.08M81.36M35.00M26.00M46.50M49.75M68.25M37.00M34.36M42.79M29.50M71.70M36.20M40.09M6.40M8.50M24.46M
Cash from Investing Activities (Quarter)
-260.63M-1.80M0.15M58.58M21.61M1.35M18.00M-75.43M15.04M7.74M31.22M26.12M10.73M22.12M62.19M11.52M40.09M-60.34M8.50M-65.50M
Financing Activities
Other financing activities (Quarter)
0.71M-1.25M0.15M0.06M0.09M0.13M0.03M0.32M-0.32M0.02M0.00M0.25M-0.20M0.32M0.09M0.06M0.03M0.09M
Cash from Financing Activities (Quarter)
0.71M1.95M41.55M-41.04M0.15M0.15M-0.27M111.34M0.09M25.24M-0.01M0.06M-0.13M-0.03M-0.16M0.04M-0.01M24.94M-0.31M85.82M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Change in Cash (Quarter)
-281.69M-25.55M19.81M-0.93M1.32M-21.42M-12.40M8.24M-10.55M9.39M-0.58M3.12M-16.69M1.34M27.80M-14.52M20.97M-12.28M-13.50M4.74M
Free Cash Flow (Quarter)
-23.41M-24.48M-22.25M-19.82M-19.05M-22.69M-30.94M-28.65M-26.27M-24.71M-32.08M-23.42M-27.36M-20.04M-34.28M-26.09M-19.11M23.12M-21.68M-15.60M
Net Cash Flow (Quarter)
-281.69M-25.55M19.81M-0.93M1.32M-21.42M-12.40M8.24M-10.55M9.39M-0.58M3.12M-16.69M1.34M27.80M-14.52M20.97M-12.28M-13.50M4.74M